95 filings
8-K
DTIL
Precision Biosciences Inc
16 Apr 24
Precision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail Therapeutics
4:47pm
8-K
DTIL
Precision Biosciences Inc
27 Mar 24
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
7:15am
8-K
DTIL
Precision Biosciences Inc
1 Mar 24
Precision BioSciences Announces $40.0 Million Offering of Common Stock and Warrants
8:00am
8-K
DTIL
Precision Biosciences Inc
13 Feb 24
Amendments to Articles of Incorporation or Bylaws
8:29am
8-K
DTIL
Precision Biosciences Inc
23 Jan 24
Departure of Directors or Certain Officers
5:29pm
8-K
410ag
19 Jan 24
Submission of Matters to a Vote of Security Holders
7:30am
8-K
s113i0gb0ij2a2ebb
11 Jan 24
Precision BioSciences Completes License Deal with TG Therapeutics for Cell Therapy Azer-Cel in Treatment of Autoimmune Diseases
8:31am
8-K
ft9l0
22 Dec 23
Amendments to Articles of Incorporation or Bylaws
8:12am
8-K
90bk0ch
7 Nov 23
Precision BioSciences Reports Third Quarter 2023 Financial Results and Provides Business Update
7:15am
8-K
gc1igzwkh7xzsqadxz
25 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:00am
8-K/A
0q7xafxd5w
20 Oct 23
Entry into a Material Definitive Agreement
5:03pm
8-K
2kg8tw8il jq9ko7in
19 Oct 23
Entry into a Material Definitive Agreement
7:00am
8-K
brh yr6exe
12 Sep 23
Precision BioSciences Hosts Virtual R&D Day Highlighting its Proprietary ARCUS Technology and Recent In Vivo Gene Editing Program Developments
7:02am
8-K
ib0ehbtdofov4
7 Sep 23
Departure of Directors or Certain Officers
7:00am
8-K/A
8g5uanwnjs0wlc 45nc1
21 Aug 23
Unaudited Pro Forma Condensed Consolidated Financial Statements
7:00am
8-K
gvu4q7a8y3c81zti
15 Aug 23
Precision BioSciences Completes Strategic Transaction with Imugene for Azer-Cel in Cancer
7:30pm
8-K
skco2r7h
4 Aug 23
Precision BioSciences Reports Second Quarter 2023 Financial Results and Provides Business Update
7:42am
8-K
3lt6i4 ivqy62n
6 Jul 23
Entry into a Material Definitive Agreement
8:00am
8-K
oim nsp62jk
31 May 23
Precision BioSciences Provides Update on Allogeneic CAR T Programs and Regulatory Path Forward
7:31am
8-K
u7b08ayxk8
9 May 23
Submission of Matters to a Vote of Security Holders
4:20pm